ASN
ZSAN

Advisory Services Network’s Zosano Pharma Corporation ZSAN Stock Holding History

Advisory Services Network’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3
Closed – – 3607
2021
Q2 		$0 Buy
+3
New +$97 ﹤0.01% 3688

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Advisory Services Network's ZSAN Position: Q3 2021 in Review

Advisory Services Network sold out of Zosano Pharma Corporation (ZSAN) in Q3 2021, closing a stake of 3 shares.

Advisory Services Network first reported a position in ZSAN in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 32 funds tracked by Wall St. Rank hold ZSAN as of Q3 2021.

  • Advisory Services Network reported no remaining Zosano Pharma Corporation position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 3 Zosano Pharma Corporation shares in Q3 2021.
  • Advisory Services Network first reported a position in Zosano Pharma Corporation in Q2 2021 and held it in 1 quarter.
  • Advisory Services Network's Zosano Pharma Corporation position peaked at $0 in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.